Abstract: The present disclosure relates to antibodies that specifically bind human IL-4Ra, compositions comprising such IL-4Ra antibodies, and methods of using such IL-4Ra antibodies.
| # | Name | Date |
|---|---|---|
| 1 | 202417013015-STATEMENT OF UNDERTAKING (FORM 3) [23-02-2024(online)].pdf | 2024-02-23 |
| 3 | 202417013015-Sequence Listing in txt [23-02-2024(online)].txt | 2024-02-23 |
| 4 | 202417013015-Sequence Listing in PDF [23-02-2024(online)].pdf | 2024-02-23 |
| 5 | 202417013015-PRIORITY DOCUMENTS [23-02-2024(online)].pdf | 2024-02-23 |
| 6 | 202417013015-POWER OF AUTHORITY [23-02-2024(online)].pdf | 2024-02-23 |
| 7 | 202417013015-FORM 18 [23-02-2024(online)].pdf | 2024-02-23 |
| 8 | 202417013015-FORM 1 [23-02-2024(online)].pdf | 2024-02-23 |
| 9 | 202417013015-DRAWINGS [23-02-2024(online)].pdf | 2024-02-23 |
| 10 | 202417013015-DECLARATION OF INVENTORSHIP (FORM 5) [23-02-2024(online)].pdf | 2024-02-23 |
| 11 | 202417013015-COMPLETE SPECIFICATION [23-02-2024(online)].pdf | 2024-02-23 |
| 12 | 202417013015-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [23-02-2024(online)].pdf | 2024-02-23 |
| 13 | 202417013015-Proof of Right [12-03-2024(online)].pdf | 2024-03-12 |
| 14 | 202417013015-FORM 3 [15-03-2024(online)].pdf | 2024-03-15 |